Schumer-Manchin plan would increase medicine costs while killing innovation

Among the many wrongheaded features of the Manchin-Schumer tax-and-spendathon bill being pushed in Congress right now, the one on prescription drug pricing is a deadly vampire of a proposal which for 16 years has refused to stay deceased. After numerous rejections of the idea by previous Congresses, this bill again revives a proposal to direct … Read more

Price controls on medicines save money for the federal government, but not necessarily for consumers

[This piece has been published in Restoring America to highlight how a drug pricing proposal being considered by Congress might actually hurt consumers in the long run.] While supporters of the prescription drug pricing proposal that is under consideration may position it as a benefit to consumers, the policy won’t offer meaningful savings for many … Read more